Rank | Gene Set | Z-score |
---|---|---|
1 | neutrophil activation involved in immune response (GO:0002283) | 5.86317413 |
2 | response to peptidoglycan (GO:0032494) | 5.64173401 |
3 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.44213143 |
4 | cell adhesion mediated by integrin (GO:0033627) | 5.39422622 |
5 | hydrogen peroxide biosynthetic process (GO:0050665) | 5.30062134 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.29351085 |
7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.29351085 |
8 | modulation by symbiont of host immune response (GO:0052553) | 5.29351085 |
9 | positive regulation by symbiont of host defense response (GO:0052509) | 5.29351085 |
10 | modulation by symbiont of host defense response (GO:0052031) | 5.29351085 |
11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.29351085 |
12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.11677416 |
13 | superoxide anion generation (GO:0042554) | 4.94612702 |
14 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.90711622 |
15 | positive regulation of heat generation (GO:0031652) | 4.87694326 |
16 | protein localization to endosome (GO:0036010) | 4.75221103 |
17 | regulation of fever generation (GO:0031620) | 4.73249840 |
18 | regulation of chemokine biosynthetic process (GO:0045073) | 4.72855388 |
19 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.67842733 |
20 | reactive oxygen species biosynthetic process (GO:1903409) | 4.66791592 |
21 | granulocyte activation (GO:0036230) | 4.62723073 |
22 | respiratory burst (GO:0045730) | 4.51961983 |
23 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.49836532 |
24 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.41529798 |
25 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.36231708 |
26 | glycosphingolipid catabolic process (GO:0046479) | 4.35940404 |
27 | oligosaccharide catabolic process (GO:0009313) | 4.32304551 |
28 | neutrophil activation (GO:0042119) | 4.31308426 |
29 | macrophage activation involved in immune response (GO:0002281) | 4.14485018 |
30 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 4.09810216 |
31 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.07858107 |
32 | glycolipid catabolic process (GO:0019377) | 4.01474736 |
33 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.94391839 |
34 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.92433441 |
35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.91412000 |
36 | immunoglobulin mediated immune response (GO:0016064) | 3.90687025 |
37 | T-helper 1 type immune response (GO:0042088) | 3.85160750 |
38 | positive regulation of interferon-alpha production (GO:0032727) | 3.79722100 |
39 | positive regulation of mast cell degranulation (GO:0043306) | 3.78903221 |
40 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.78903221 |
41 | negative regulation of interleukin-17 production (GO:0032700) | 3.78613060 |
42 | regulation of heat generation (GO:0031650) | 3.77546653 |
43 | wound healing, spreading of epidermal cells (GO:0035313) | 3.75458324 |
44 | regulation of mononuclear cell migration (GO:0071675) | 3.68917462 |
45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.68626555 |
46 | response to host immune response (GO:0052572) | 3.68626555 |
47 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.68438792 |
48 | regulation of activation of Janus kinase activity (GO:0010533) | 3.65026339 |
49 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.62823197 |
50 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.62571812 |
51 | regulation of interferon-alpha production (GO:0032647) | 3.61617378 |
52 | leukocyte aggregation (GO:0070486) | 3.58932265 |
53 | regulation of macrophage chemotaxis (GO:0010758) | 3.57345780 |
54 | detection of molecule of bacterial origin (GO:0032490) | 3.57023157 |
55 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.55272739 |
56 | cellular response to arsenic-containing substance (GO:0071243) | 3.53961824 |
57 | eosinophil chemotaxis (GO:0048245) | 3.52634401 |
58 | membrane lipid catabolic process (GO:0046466) | 3.52104195 |
59 | regulation of early endosome to late endosome transport (GO:2000641) | 3.51071892 |
60 | response to lipoprotein particle (GO:0055094) | 3.50813555 |
61 | defense response to protozoan (GO:0042832) | 3.50781805 |
62 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.50101594 |
63 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.49825616 |
64 | negative regulation of lipid storage (GO:0010888) | 3.47212639 |
65 | ceramide catabolic process (GO:0046514) | 3.45468945 |
66 | regulation of vascular endothelial growth factor production (GO:0010574) | 3.42756631 |
67 | substrate-dependent cell migration (GO:0006929) | 3.42299595 |
68 | myeloid cell activation involved in immune response (GO:0002275) | 3.39877769 |
69 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.36390790 |
70 | microglial cell activation (GO:0001774) | 3.35393818 |
71 | response to muramyl dipeptide (GO:0032495) | 3.31166978 |
72 | response to thyroid hormone (GO:0097066) | 3.30906436 |
73 | positive regulation of mast cell activation (GO:0033005) | 3.30033691 |
74 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.29645794 |
75 | positive regulation of extracellular matrix organization (GO:1903055) | 3.28445188 |
76 | eosinophil migration (GO:0072677) | 3.28217144 |
77 | macrophage activation (GO:0042116) | 3.24336078 |
78 | response to host (GO:0075136) | 3.23647632 |
79 | response to host defenses (GO:0052200) | 3.23647632 |
80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.23647632 |
81 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.22702032 |
82 | regulation of interleukin-17 production (GO:0032660) | 3.22573813 |
83 | regulation of chronic inflammatory response (GO:0002676) | 3.20652546 |
84 | positive regulation of type 2 immune response (GO:0002830) | 3.20103881 |
85 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.19520619 |
86 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.19322225 |
87 | osteoclast differentiation (GO:0030316) | 3.18855813 |
88 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.17196387 |
89 | regulation of cholesterol storage (GO:0010885) | 3.17182082 |
90 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.16118314 |
91 | apoptotic cell clearance (GO:0043277) | 3.15905082 |
92 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.15783255 |
93 | positive regulation of chemokine production (GO:0032722) | 3.15092982 |
94 | neutrophil mediated immunity (GO:0002446) | 3.13702639 |
95 | monocyte chemotaxis (GO:0002548) | 3.13546272 |
96 | cellular response to zinc ion (GO:0071294) | 3.13393268 |
97 | regulation of vitamin metabolic process (GO:0030656) | 3.13253608 |
98 | iron ion import (GO:0097286) | 3.12991583 |
99 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.11550331 |
100 | natural killer cell mediated immunity (GO:0002228) | 3.10963339 |
101 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.10963339 |
102 | positive regulation of interleukin-12 production (GO:0032735) | 3.09356137 |
103 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.08302631 |
104 | regulation of mast cell degranulation (GO:0043304) | 3.07449681 |
105 | negative regulation of interleukin-12 production (GO:0032695) | 3.07097992 |
106 | positive regulation of interleukin-17 production (GO:0032740) | 3.06259732 |
107 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.04646749 |
108 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.03044733 |
109 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.02926381 |
110 | positive regulation vascular endothelial growth factor production (GO:0010575) | 3.02588482 |
111 | regulation of immunoglobulin secretion (GO:0051023) | 3.00227448 |
112 | phagosome maturation (GO:0090382) | 2.99069011 |
113 | skin morphogenesis (GO:0043589) | 2.97485855 |
114 | positive regulation of acute inflammatory response (GO:0002675) | 2.97260711 |
115 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.96939682 |
116 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96887409 |
117 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.96458547 |
118 | positive regulation of interleukin-6 production (GO:0032755) | 2.96130370 |
119 | response to protozoan (GO:0001562) | 2.95824487 |
120 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.92924064 |
121 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.92022237 |
122 | positive regulation of interleukin-10 production (GO:0032733) | 2.91502550 |
123 | positive regulation of leukocyte degranulation (GO:0043302) | 2.88843429 |
124 | leukocyte mediated cytotoxicity (GO:0001909) | 2.88575483 |
125 | sphingosine metabolic process (GO:0006670) | 2.88243641 |
126 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.88120058 |
127 | positive regulation of leukocyte migration (GO:0002687) | 2.87308425 |
128 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.85814144 |
129 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.85725201 |
130 | positive regulation of leukocyte chemotaxis (GO:0002690) | 2.84595805 |
131 | regulation of podosome assembly (GO:0071801) | 2.84236273 |
132 | neutrophil chemotaxis (GO:0030593) | 2.84088464 |
133 | superoxide metabolic process (GO:0006801) | 2.84077473 |
134 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.83982731 |
135 | endodermal cell differentiation (GO:0035987) | 2.83623111 |
136 | positive regulation of interferon-beta production (GO:0032728) | 2.83286092 |
137 | cellular response to ethanol (GO:0071361) | 2.83198833 |
138 | glial cell migration (GO:0008347) | 2.82423829 |
139 | decidualization (GO:0046697) | 2.80165266 |
140 | sphingolipid catabolic process (GO:0030149) | 2.79719766 |
141 | cellular response to lipopolysaccharide (GO:0071222) | 2.79120701 |
142 | epithelial cell-cell adhesion (GO:0090136) | 2.77391630 |
143 | cellular extravasation (GO:0045123) | 2.76777239 |
144 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.71802226 |
145 | mRNA transcription (GO:0009299) | 2.71277889 |
146 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.70737026 |
147 | regulation of integrin activation (GO:0033623) | 2.69538596 |
148 | response to arsenic-containing substance (GO:0046685) | 2.68255017 |
149 | regulation of monocyte chemotaxis (GO:0090025) | 2.66504948 |
150 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.65118006 |
151 | hypotonic response (GO:0006971) | 2.64206792 |
152 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.64105299 |
153 | cellular response to molecule of bacterial origin (GO:0071219) | 2.63600556 |
154 | barbed-end actin filament capping (GO:0051016) | 2.63497064 |
155 | granulocyte chemotaxis (GO:0071621) | 2.58000078 |
156 | regulation of prostaglandin secretion (GO:0032306) | 2.57563888 |
157 | wound healing, spreading of cells (GO:0044319) | 2.56536899 |
158 | hyaluronan catabolic process (GO:0030214) | 2.54198925 |
159 | negative regulation of focal adhesion assembly (GO:0051895) | 2.53655425 |
160 | negative regulation of cell junction assembly (GO:1901889) | 2.53655425 |
161 | negative regulation of adherens junction organization (GO:1903392) | 2.53655425 |
162 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.49529998 |
163 | response to laminar fluid shear stress (GO:0034616) | 2.49222712 |
164 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.49120616 |
165 | nuclear pore complex assembly (GO:0051292) | 2.48287935 |
166 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.46249970 |
167 | pore complex assembly (GO:0046931) | 2.46033778 |
168 | granulocyte migration (GO:0097530) | 2.44251162 |
169 | mammary gland epithelial cell proliferation (GO:0033598) | 2.43876441 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.45823810 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.39383265 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.96749274 |
4 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.92768273 |
5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.81202288 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.68591752 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.54469914 |
8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.53437820 |
9 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.37910842 |
10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.32098013 |
11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.11202237 |
12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05072164 |
13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.70221490 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.56698881 |
15 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.48042367 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43528001 |
17 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.37972344 |
18 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.37972344 |
19 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.31573825 |
20 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.18522937 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.16278793 |
22 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.09177192 |
23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.01324461 |
24 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.00293421 |
25 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.97666244 |
26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.95443116 |
27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.93331584 |
28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.91964891 |
29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.91065596 |
30 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.87625439 |
31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.80065433 |
32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.79422074 |
33 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.76726727 |
34 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.64851399 |
35 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.63179141 |
36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.62508939 |
37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.61498883 |
38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.60822991 |
39 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.59305236 |
40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.58901413 |
41 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58862765 |
42 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.57376548 |
43 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.57376548 |
44 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.56589281 |
45 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.56347542 |
46 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.55697229 |
47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.54018170 |
48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51612339 |
49 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.45520091 |
50 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.45166670 |
51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44679177 |
52 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42042439 |
53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41315737 |
54 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.40723672 |
55 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39431680 |
56 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.37717331 |
57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36426814 |
58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30662488 |
59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30189536 |
60 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.30086485 |
61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29164116 |
62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28770397 |
63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28726162 |
64 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.28686047 |
65 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27358189 |
66 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26135068 |
67 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25070253 |
68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.23555398 |
69 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22334061 |
70 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22251470 |
71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20129759 |
72 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.19806267 |
73 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18219343 |
74 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17435686 |
75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15940765 |
76 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15526881 |
77 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13519247 |
78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12024996 |
79 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.10936354 |
80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10707649 |
81 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10205317 |
82 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.08008291 |
83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07918365 |
84 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.07582276 |
85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06739071 |
86 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03799003 |
87 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03610632 |
88 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.03603450 |
89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03577165 |
90 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.02691770 |
91 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00206673 |
92 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00068311 |
93 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99785903 |
94 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.98689670 |
95 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98182453 |
96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98154510 |
97 | SPI1_23127762_ChIP-Seq_K562_Human | 0.97924471 |
98 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.96770214 |
99 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.95142265 |
100 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94654848 |
101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93891092 |
102 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.92285427 |
103 | MYB_26560356_Chip-Seq_TH2_Human | 0.91543780 |
104 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91135939 |
105 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90874701 |
106 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90666881 |
107 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90480748 |
108 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.90317055 |
109 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.89714321 |
110 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89691341 |
111 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89242307 |
112 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89132699 |
113 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89018036 |
114 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.87850709 |
115 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.87220405 |
116 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.86979809 |
117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86596935 |
118 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86063124 |
119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85526705 |
120 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85183625 |
121 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85037126 |
122 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84997415 |
123 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83964957 |
124 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.83290583 |
125 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.83255356 |
126 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.82024711 |
127 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.81194418 |
128 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.80977498 |
129 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.80718391 |
130 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80610008 |
131 | TP53_16413492_ChIP-PET_HCT116_Human | 0.80339065 |
132 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78619846 |
133 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.78172223 |
134 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.77793408 |
135 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.77697878 |
136 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.77452236 |
137 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.76468978 |
138 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.76451241 |
139 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76132952 |
140 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.76013289 |
141 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.75940437 |
142 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.75919006 |
143 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75823646 |
144 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.74342501 |
145 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.73445622 |
146 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.73341428 |
147 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.72871988 |
148 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72332762 |
149 | VDR_22108803_ChIP-Seq_LS180_Human | 0.72187370 |
150 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.72123620 |
151 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.71822412 |
152 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.71804482 |
153 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.71037373 |
154 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70802693 |
155 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.70088156 |
156 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.69836875 |
157 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.69230701 |
158 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.68181411 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009785_altered_susceptibility_to | 4.68186669 |
2 | MP0001835_abnormal_antigen_presentation | 4.39434272 |
3 | MP0002148_abnormal_hypersensitivity_rea | 4.16442675 |
4 | MP0003436_decreased_susceptibility_to | 3.97085456 |
5 | MP0002877_abnormal_melanocyte_morpholog | 3.83188990 |
6 | MP0009840_abnormal_foam_cell | 3.82613625 |
7 | MP0003724_increased_susceptibility_to | 3.68360334 |
8 | MP0006082_CNS_inflammation | 3.57332998 |
9 | * MP0002419_abnormal_innate_immunity | 3.51283196 |
10 | MP0005000_abnormal_immune_tolerance | 3.40795255 |
11 | MP0003705_abnormal_hypodermis_morpholog | 3.17319867 |
12 | MP0005025_abnormal_response_to | 3.16810289 |
13 | MP0003303_peritoneal_inflammation | 3.09328958 |
14 | MP0009764_decreased_sensitivity_to | 2.63146585 |
15 | MP0010352_gastrointestinal_tract_polyps | 2.62083492 |
16 | MP0001790_abnormal_immune_system | 2.57930225 |
17 | MP0005387_immune_system_phenotype | 2.57930225 |
18 | * MP0002452_abnormal_antigen_presenting | 2.55524047 |
19 | MP0004233_abnormal_muscle_weight | 2.54224300 |
20 | MP0005671_abnormal_response_to | 2.53358863 |
21 | MP0002723_abnormal_immune_serum | 2.45913245 |
22 | MP0004510_myositis | 2.45734864 |
23 | MP0000685_abnormal_immune_system | 2.44124080 |
24 | MP0006054_spinal_hemorrhage | 2.43947549 |
25 | MP0008438_abnormal_cutaneous_collagen | 2.39187687 |
26 | MP0005167_abnormal_blood-brain_barrier | 2.30679847 |
27 | MP0003806_abnormal_nucleotide_metabolis | 2.25201292 |
28 | MP0002006_tumorigenesis | 2.22468034 |
29 | MP0001800_abnormal_humoral_immune | 2.19787064 |
30 | MP0003950_abnormal_plasma_membrane | 2.16377860 |
31 | MP0003075_altered_response_to | 2.14951586 |
32 | MP0001533_abnormal_skeleton_physiology | 2.12284395 |
33 | MP0003300_gastrointestinal_ulcer | 2.09808934 |
34 | * MP0001819_abnormal_immune_cell | 2.07102831 |
35 | * MP0002420_abnormal_adaptive_immunity | 2.01848552 |
36 | MP0001853_heart_inflammation | 2.01526376 |
37 | MP0005058_abnormal_lysosome_morphology | 1.99986166 |
38 | MP0004947_skin_inflammation | 1.98080535 |
39 | MP0003566_abnormal_cell_adhesion | 1.95135967 |
40 | MP0001845_abnormal_inflammatory_respons | 1.94279079 |
41 | MP0003195_calcinosis | 1.90802107 |
42 | MP0003448_altered_tumor_morphology | 1.85800473 |
43 | MP0003656_abnormal_erythrocyte_physiolo | 1.84825336 |
44 | MP0002405_respiratory_system_inflammati | 1.80622483 |
45 | MP0002139_abnormal_hepatobiliary_system | 1.79211982 |
46 | MP0002998_abnormal_bone_remodeling | 1.76101689 |
47 | MP0003941_abnormal_skin_development | 1.70380465 |
48 | MP0008469_abnormal_protein_level | 1.66021272 |
49 | MP0000343_altered_response_to | 1.65819747 |
50 | * MP0005464_abnormal_platelet_physiology | 1.63425056 |
51 | MP0010234_abnormal_vibrissa_follicle | 1.57554517 |
52 | MP0005310_abnormal_salivary_gland | 1.55798399 |
53 | MP0009278_abnormal_bone_marrow | 1.54807932 |
54 | MP0002254_reproductive_system_inflammat | 1.52750108 |
55 | MP0002277_abnormal_respiratory_mucosa | 1.52651975 |
56 | MP0003186_abnormal_redox_activity | 1.52147459 |
57 | MP0005166_decreased_susceptibility_to | 1.52064776 |
58 | MP0000858_altered_metastatic_potential | 1.50639498 |
59 | MP0003828_pulmonary_edema | 1.48375998 |
60 | MP0004272_abnormal_basement_membrane | 1.47990414 |
61 | MP0010155_abnormal_intestine_physiology | 1.45795394 |
62 | MP0005164_abnormal_response_to | 1.45665163 |
63 | MP0005023_abnormal_wound_healing | 1.45354281 |
64 | MP0010678_abnormal_skin_adnexa | 1.39041399 |
65 | MP0000569_abnormal_digit_pigmentation | 1.36408760 |
66 | MP0002332_abnormal_exercise_endurance | 1.35772315 |
67 | MP0003690_abnormal_glial_cell | 1.33901599 |
68 | MP0010307_abnormal_tumor_latency | 1.33499526 |
69 | MP0000716_abnormal_immune_system | 1.31385521 |
70 | MP0009333_abnormal_splenocyte_physiolog | 1.28161114 |
71 | MP0008260_abnormal_autophagy | 1.27667799 |
72 | MP0001849_ear_inflammation | 1.27627134 |
73 | MP0005171_absent_coat_pigmentation | 1.26122321 |
74 | MP0003136_yellow_coat_color | 1.25275182 |
75 | MP0004858_abnormal_nervous_system | 1.21242756 |
76 | MP0004782_abnormal_surfactant_physiolog | 1.20581510 |
77 | MP0000383_abnormal_hair_follicle | 1.16429031 |
78 | MP0002896_abnormal_bone_mineralization | 1.15000791 |
79 | MP0003646_muscle_fatigue | 1.13784385 |
80 | MP0005390_skeleton_phenotype | 1.11653240 |
81 | MP0003172_abnormal_lysosome_physiology | 1.11047895 |
82 | MP0005197_abnormal_uvea_morphology | 1.09321590 |
83 | MP0001915_intracranial_hemorrhage | 1.08942898 |
84 | MP0004185_abnormal_adipocyte_glucose | 1.07140235 |
85 | MP0003329_amyloid_beta_deposits | 1.05199143 |
86 | MP0008007_abnormal_cellular_replicative | 1.05006303 |
87 | MP0003279_aneurysm | 1.04366269 |
88 | MP0002398_abnormal_bone_marrow | 1.02681449 |
89 | MP0001501_abnormal_sleep_pattern | 1.00374811 |
90 | MP0001542_abnormal_bone_strength | 0.98278152 |
91 | MP0001545_abnormal_hematopoietic_system | 0.96757296 |
92 | MP0005397_hematopoietic_system_phenotyp | 0.96757296 |
93 | MP0009763_increased_sensitivity_to | 0.96332250 |
94 | MP0005451_abnormal_body_composition | 0.96082873 |
95 | MP0003183_abnormal_peptide_metabolism | 0.95231107 |
96 | MP0005595_abnormal_vascular_smooth | 0.95057354 |
97 | MP0000604_amyloidosis | 0.93403806 |
98 | MP0002429_abnormal_blood_cell | 0.92669555 |
99 | MP0001243_abnormal_dermal_layer | 0.88952205 |
100 | MP0004808_abnormal_hematopoietic_stem | 0.86717601 |
101 | MP0002933_joint_inflammation | 0.85801376 |
102 | MP0003453_abnormal_keratinocyte_physiol | 0.83195854 |
103 | * MP0000371_diluted_coat_color | 0.82812621 |
104 | MP0001216_abnormal_epidermal_layer | 0.81117335 |
105 | MP0000920_abnormal_myelination | 0.78477190 |
106 | MP0002060_abnormal_skin_morphology | 0.77342995 |
107 | MP0000372_irregular_coat_pigmentation | 0.77136573 |
108 | MP0001851_eye_inflammation | 0.76743137 |
109 | MP0010386_abnormal_urinary_bladder | 0.75440157 |
110 | MP0000689_abnormal_spleen_morphology | 0.74590459 |
111 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74008274 |
112 | MP0009765_abnormal_xenobiotic_induced | 0.73615533 |
113 | MP0000750_abnormal_muscle_regeneration | 0.72051284 |
114 | MP0003634_abnormal_glial_cell | 0.71938906 |
115 | MP0000249_abnormal_blood_vessel | 0.71466305 |
116 | MP0002295_abnormal_pulmonary_circulatio | 0.71065669 |
117 | MP0003191_abnormal_cellular_cholesterol | 0.70510548 |
118 | MP0005076_abnormal_cell_differentiation | 0.69854605 |
119 | MP0005621_abnormal_cell_physiology | 0.68833912 |
120 | MP0002722_abnormal_immune_system | 0.68766241 |
121 | MP0001191_abnormal_skin_condition | 0.68632120 |
122 | MP0005623_abnormal_meninges_morphology | 0.68403936 |
123 | MP0005647_abnormal_sex_gland | 0.67332551 |
124 | MP0005535_abnormal_body_temperature | 0.66321078 |
125 | MP0004883_abnormal_blood_vessel | 0.65082854 |
126 | MP0003795_abnormal_bone_structure | 0.64803128 |
127 | MP0000767_abnormal_smooth_muscle | 0.64459985 |
128 | MP0002166_altered_tumor_susceptibility | 0.63686213 |
129 | MP0005174_abnormal_tail_pigmentation | 0.62873909 |
130 | MP0003091_abnormal_cell_migration | 0.56854502 |
131 | MP0003045_fibrosis | 0.55348108 |
132 | MP0005257_abnormal_intraocular_pressure | 0.55196654 |
133 | MP0002136_abnormal_kidney_physiology | 0.54564742 |
134 | MP0008004_abnormal_stomach_pH | 0.54202987 |
135 | MP0002638_abnormal_pupillary_reflex | 0.49830539 |
136 | MP0002693_abnormal_pancreas_physiology | 0.49126148 |
137 | MP0002163_abnormal_gland_morphology | 0.48592272 |
138 | MP0005165_increased_susceptibility_to | 0.47302941 |
139 | MP0002138_abnormal_hepatobiliary_system | 0.46970073 |
140 | MP0001346_abnormal_lacrimal_gland | 0.46606412 |
141 | MP0000015_abnormal_ear_pigmentation | 0.46242152 |
142 | MP0002090_abnormal_vision | 0.44752485 |
143 | MP0002168_other_aberrant_phenotype | 0.44617011 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 8.37081035 |
2 | Recurrent abscess formation (HP:0002722) | 8.33968455 |
3 | Recurrent bacterial skin infections (HP:0005406) | 7.83378133 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.48198989 |
5 | Mediastinal lymphadenopathy (HP:0100721) | 6.49015299 |
6 | Abnormality of macrophages (HP:0004311) | 5.60196319 |
7 | Stomatitis (HP:0010280) | 5.37080502 |
8 | Gingivitis (HP:0000230) | 4.99950475 |
9 | Increased IgM level (HP:0003496) | 4.79775952 |
10 | Recurrent skin infections (HP:0001581) | 4.63188927 |
11 | Neurofibrillary tangles (HP:0002185) | 4.45057236 |
12 | Chronic obstructive pulmonary disease (HP:0006510) | 4.44066816 |
13 | Obstructive lung disease (HP:0006536) | 4.44066816 |
14 | Optic neuritis (HP:0100653) | 4.41590157 |
15 | Retrobulbar optic neuritis (HP:0100654) | 4.41590157 |
16 | Autoimmune thrombocytopenia (HP:0001973) | 4.40532121 |
17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.23555456 |
18 | Orchitis (HP:0100796) | 4.16680512 |
19 | Recurrent fungal infections (HP:0002841) | 3.87907150 |
20 | Vasculitis (HP:0002633) | 3.73409621 |
21 | Myositis (HP:0100614) | 3.71533651 |
22 | Nuclear cataract (HP:0100018) | 3.55363598 |
23 | Loss of speech (HP:0002371) | 3.53608448 |
24 | Tetraparesis (HP:0002273) | 3.48466879 |
25 | Thick nail (HP:0001805) | 3.41651893 |
26 | Premature rupture of membranes (HP:0001788) | 3.39533148 |
27 | Cerebral inclusion bodies (HP:0100314) | 3.36462477 |
28 | Basal ganglia calcification (HP:0002135) | 3.30183897 |
29 | Prostate neoplasm (HP:0100787) | 3.29566577 |
30 | Urticaria (HP:0001025) | 3.22543573 |
31 | Pulmonary infiltrates (HP:0002113) | 3.13632042 |
32 | Recurrent viral infections (HP:0004429) | 3.13380389 |
33 | Periodontitis (HP:0000704) | 3.12436426 |
34 | Cortical dysplasia (HP:0002539) | 3.11862447 |
35 | Vacuolated lymphocytes (HP:0001922) | 3.07448298 |
36 | Recurrent pneumonia (HP:0006532) | 3.06283726 |
37 | Upper limb muscle weakness (HP:0003484) | 3.00198751 |
38 | Gastrointestinal infarctions (HP:0005244) | 2.99854932 |
39 | Cellulitis (HP:0100658) | 2.99117172 |
40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91656986 |
41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91656986 |
42 | Axonal loss (HP:0003447) | 2.91138334 |
43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.90196655 |
44 | Poor head control (HP:0002421) | 2.84762779 |
45 | Interstitial pulmonary disease (HP:0006530) | 2.79547929 |
46 | Meningitis (HP:0001287) | 2.75541137 |
47 | Increased cerebral lipofuscin (HP:0011813) | 2.75269788 |
48 | Multiple enchondromatosis (HP:0005701) | 2.74066240 |
49 | Systemic lupus erythematosus (HP:0002725) | 2.71690087 |
50 | Hypergammaglobulinemia (HP:0010702) | 2.62904236 |
51 | Skin nodule (HP:0200036) | 2.62205282 |
52 | Apathy (HP:0000741) | 2.61852679 |
53 | Premature loss of primary teeth (HP:0006323) | 2.61708211 |
54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61280802 |
55 | Mucopolysacchariduria (HP:0008155) | 2.61280802 |
56 | Metaphyseal irregularity (HP:0003025) | 2.58221439 |
57 | Mutism (HP:0002300) | 2.56170451 |
58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.54983878 |
59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.54983878 |
60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.54983878 |
61 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.54788162 |
62 | Pustule (HP:0200039) | 2.53891799 |
63 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.53791761 |
64 | Recurrent lower respiratory tract infections (HP:0002783) | 2.53307697 |
65 | Diminished motivation (HP:0000745) | 2.52645011 |
66 | Keratoconjunctivitis sicca (HP:0001097) | 2.51371161 |
67 | Short nail (HP:0001799) | 2.49000889 |
68 | Atrophic scars (HP:0001075) | 2.48829727 |
69 | Osteomyelitis (HP:0002754) | 2.48005593 |
70 | Leukocytosis (HP:0001974) | 2.46625968 |
71 | Upper motor neuron abnormality (HP:0002127) | 2.45038683 |
72 | Hemoptysis (HP:0002105) | 2.43190307 |
73 | Subacute progressive viral hepatitis (HP:0006572) | 2.42024793 |
74 | Spastic diplegia (HP:0001264) | 2.41484372 |
75 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.39062999 |
76 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.39062999 |
77 | Abnormality of glycolipid metabolism (HP:0010969) | 2.39062999 |
78 | Spondylolisthesis (HP:0003302) | 2.37985450 |
79 | Myocardial infarction (HP:0001658) | 2.37842432 |
80 | Glomerulonephritis (HP:0000099) | 2.36438010 |
81 | Nephritis (HP:0000123) | 2.34884951 |
82 | Arterial thrombosis (HP:0004420) | 2.32378009 |
83 | Keratoconjunctivitis (HP:0001096) | 2.31994047 |
84 | Disinhibition (HP:0000734) | 2.31498634 |
85 | Gingival bleeding (HP:0000225) | 2.29372722 |
86 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.23325158 |
87 | Abnormality of the pericardium (HP:0001697) | 2.22637749 |
88 | Esophageal varix (HP:0002040) | 2.21938861 |
89 | Autoimmune hemolytic anemia (HP:0001890) | 2.21297471 |
90 | Sepsis (HP:0100806) | 2.19102414 |
91 | Epidermoid cyst (HP:0200040) | 2.18950231 |
92 | Porencephaly (HP:0002132) | 2.17354567 |
93 | Fused cervical vertebrae (HP:0002949) | 2.16779605 |
94 | Inappropriate behavior (HP:0000719) | 2.13267720 |
95 | Natal tooth (HP:0000695) | 2.09527851 |
96 | Abnormality of T cell number (HP:0011839) | 2.09420609 |
97 | Protrusio acetabuli (HP:0003179) | 2.07488515 |
98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04743612 |
99 | Multiple lipomas (HP:0001012) | 2.04432886 |
100 | Joint hemorrhage (HP:0005261) | 2.03158593 |
101 | Bone pain (HP:0002653) | 2.03116550 |
102 | Parakeratosis (HP:0001036) | 2.03055709 |
103 | Abnormality of the periventricular white matter (HP:0002518) | 1.98245014 |
104 | Global brain atrophy (HP:0002283) | 1.98154168 |
105 | Cervical subluxation (HP:0003308) | 1.98047488 |
106 | Nausea (HP:0002018) | 1.97319222 |
107 | Anorexia (HP:0002039) | 1.94474222 |
108 | Joint swelling (HP:0001386) | 1.92963821 |
109 | Thin bony cortex (HP:0002753) | 1.92103384 |
110 | Arthralgia (HP:0002829) | 1.91674163 |
111 | Abnormality of the pleura (HP:0002103) | 1.90391646 |
112 | Hematochezia (HP:0002573) | 1.89029129 |
113 | Aplasia cutis congenita (HP:0001057) | 1.88173883 |
114 | Purpura (HP:0000979) | 1.86433505 |
115 | Neuronal loss in central nervous system (HP:0002529) | 1.85470451 |
116 | Gangrene (HP:0100758) | 1.84655126 |
117 | Gastrointestinal stroma tumor (HP:0100723) | 1.82598365 |
118 | Abnormality of oral frenula (HP:0000190) | 1.82409508 |
119 | Xanthomatosis (HP:0000991) | 1.79060368 |
120 | Abnormality of the nasal septum (HP:0000419) | 1.78542618 |
121 | Femoral bowing (HP:0002980) | 1.76864558 |
122 | Peritonitis (HP:0002586) | 1.76099741 |
123 | Ankyloglossia (HP:0010296) | 1.75219480 |
124 | Cheilitis (HP:0100825) | 1.75130386 |
125 | Petechiae (HP:0000967) | 1.74873645 |
126 | Absent frontal sinuses (HP:0002688) | 1.74750651 |
127 | Conjunctival telangiectasia (HP:0000524) | 1.73630488 |
128 | Dysostosis multiplex (HP:0000943) | 1.73253081 |
129 | Tibial bowing (HP:0002982) | 1.72286602 |
130 | Progressive visual loss (HP:0000529) | 1.72220617 |
131 | Prolonged neonatal jaundice (HP:0006579) | 1.70227093 |
132 | Buphthalmos (HP:0000557) | 1.69832883 |
133 | Hepatosplenomegaly (HP:0001433) | 1.69763832 |
134 | Pathologic fracture (HP:0002756) | 1.69498209 |
135 | T lymphocytopenia (HP:0005403) | 1.69226548 |
136 | Vertebral compression fractures (HP:0002953) | 1.68796522 |
137 | Eosinophilia (HP:0001880) | 1.68574759 |
138 | Abnormality of the prostate (HP:0008775) | 1.68111070 |
139 | Syringomyelia (HP:0003396) | 1.66916358 |
140 | Spinal cord lesions (HP:0100561) | 1.66916358 |
141 | Abnormal trabecular bone morphology (HP:0100671) | 1.66747332 |
142 | Arterial tortuosity (HP:0005116) | 1.66573467 |
143 | Hyperacusis (HP:0010780) | 1.66237721 |
144 | Termporal pattern (HP:0011008) | 1.66104568 |
145 | Insidious onset (HP:0003587) | 1.66104568 |
146 | Zonular cataract (HP:0010920) | 1.65770218 |
147 | Thyroiditis (HP:0100646) | 1.64993084 |
148 | Congenital sensorineural hearing impairment (HP:0008527) | 1.64771259 |
149 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.64652192 |
150 | Osteolytic defects of the hand bones (HP:0009699) | 1.64652192 |
151 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.64564419 |
152 | Ankle contracture (HP:0006466) | 1.64365044 |
153 | Albinism (HP:0001022) | 1.64264109 |
154 | Dysphonia (HP:0001618) | 1.63552169 |
155 | Agnosia (HP:0010524) | 1.63481739 |
156 | Protuberant abdomen (HP:0001538) | 1.63286426 |
157 | Increased serum ferritin (HP:0003281) | 1.62214505 |
158 | Ovoid vertebral bodies (HP:0003300) | 1.62033197 |
159 | Skin ulcer (HP:0200042) | 1.61957749 |
160 | Vascular tortuosity (HP:0004948) | 1.61205846 |
161 | Pseudobulbar signs (HP:0002200) | 1.60464423 |
162 | Anhidrosis (HP:0000970) | 1.60080503 |
163 | Thoracic kyphosis (HP:0002942) | 1.59536635 |
164 | Coarse hair (HP:0002208) | 1.58325732 |
165 | Insomnia (HP:0100785) | 1.58319193 |
166 | Congenital glaucoma (HP:0001087) | 1.57440757 |
167 | Fragile skin (HP:0001030) | 1.55880120 |
168 | Distal upper limb amyotrophy (HP:0007149) | 1.55427521 |
169 | Upper limb amyotrophy (HP:0009129) | 1.55427521 |
170 | Dementia (HP:0000726) | 1.54872144 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 6.65853179 |
2 | PBK | 5.22353394 |
3 | MAP3K14 | 5.08039933 |
4 | DDR2 | 3.54607610 |
5 | BLK | 3.53800255 |
6 | IRAK3 | 3.44775581 |
7 | TBK1 | 3.22455122 |
8 | IRAK4 | 2.92764241 |
9 | IKBKB | 2.56145875 |
10 | TXK | 2.54583989 |
11 | IKBKE | 2.38317063 |
12 | TTN | 2.31415524 |
13 | ACVR1B | 2.26295259 |
14 | JAK3 | 2.24890319 |
15 | PDGFRA | 2.23341637 |
16 | TYK2 | 2.11862375 |
17 | STK24 | 2.09744448 |
18 | LATS2 | 2.00339867 |
19 | BMPR2 | 1.94338954 |
20 | TGFBR2 | 1.92422669 |
21 | PDK2 | 1.86447745 |
22 | MAP3K13 | 1.73168949 |
23 | MST1R | 1.68794273 |
24 | JAK1 | 1.65826692 |
25 | YES1 | 1.58898440 |
26 | EIF2AK3 | 1.57394336 |
27 | CHUK | 1.55517401 |
28 | PAK4 | 1.48664424 |
29 | TAOK2 | 1.40797021 |
30 | BMX | 1.36024908 |
31 | MST4 | 1.34896576 |
32 | CSK | 1.33972859 |
33 | FGR | 1.29549725 |
34 | PIM2 | 1.27681339 |
35 | SCYL2 | 1.27497799 |
36 | STK38L | 1.25762546 |
37 | ERBB4 | 1.22435388 |
38 | MARK3 | 1.21873818 |
39 | ABL2 | 1.17806269 |
40 | EIF2AK2 | 1.14096340 |
41 | MAP4K1 | 1.11771698 |
42 | LYN | 1.11735402 |
43 | KIT | 1.05063050 |
44 | ICK | 1.03224107 |
45 | SYK | 1.02929668 |
46 | CDC42BPA | 0.99048268 |
47 | HCK | 0.98112066 |
48 | MAP3K9 | 0.90697878 |
49 | TGFBR1 | 0.88510315 |
50 | KSR1 | 0.87854059 |
51 | RPS6KA4 | 0.87344725 |
52 | LCK | 0.87136004 |
53 | ERBB3 | 0.86924963 |
54 | SIK3 | 0.85991179 |
55 | PRKCD | 0.85488440 |
56 | CDK6 | 0.84321922 |
57 | LIMK1 | 0.84167679 |
58 | MATK | 0.82592290 |
59 | JAK2 | 0.81229268 |
60 | PAK2 | 0.81047685 |
61 | STK4 | 0.80881730 |
62 | IRAK2 | 0.79370988 |
63 | TYRO3 | 0.79066416 |
64 | CLK1 | 0.78256345 |
65 | MAP3K8 | 0.77931879 |
66 | PIM1 | 0.76834893 |
67 | MUSK | 0.75839502 |
68 | TIE1 | 0.75397616 |
69 | MAP3K3 | 0.75304761 |
70 | TTK | 0.74878273 |
71 | NTRK1 | 0.73535203 |
72 | IRAK1 | 0.73404087 |
73 | BMPR1B | 0.73144712 |
74 | NEK1 | 0.72993261 |
75 | PTK2 | 0.72418420 |
76 | MAP3K12 | 0.70036673 |
77 | ABL1 | 0.68566257 |
78 | MAP3K5 | 0.67752825 |
79 | GRK7 | 0.66253067 |
80 | LATS1 | 0.65720052 |
81 | ZAP70 | 0.64411454 |
82 | ADRBK2 | 0.62777071 |
83 | NEK9 | 0.60929809 |
84 | CAMKK2 | 0.60598646 |
85 | BTK | 0.60237923 |
86 | TEC | 0.57541946 |
87 | TRPM7 | 0.57326412 |
88 | EPHB1 | 0.56870519 |
89 | EGFR | 0.55447655 |
90 | ERN1 | 0.55358620 |
91 | DAPK2 | 0.54605106 |
92 | NLK | 0.54360770 |
93 | NME2 | 0.53557203 |
94 | PRKCQ | 0.52904190 |
95 | FGFR3 | 0.51945167 |
96 | ALK | 0.50712114 |
97 | EIF2AK1 | 0.49999741 |
98 | PLK2 | 0.49638203 |
99 | ADRBK1 | 0.49218413 |
100 | RPS6KC1 | 0.48830975 |
101 | RPS6KL1 | 0.48830975 |
102 | TAF1 | 0.47197515 |
103 | CAMK1G | 0.47175845 |
104 | RPS6KA2 | 0.47056953 |
105 | BRSK2 | 0.46935226 |
106 | MKNK1 | 0.46554388 |
107 | TAOK3 | 0.46293884 |
108 | PRKCE | 0.45930865 |
109 | PKN1 | 0.44230707 |
110 | TNIK | 0.42541962 |
111 | STK3 | 0.41939518 |
112 | EPHA3 | 0.40412662 |
113 | FES | 0.40324142 |
114 | PRKG2 | 0.39087588 |
115 | PDGFRB | 0.38526023 |
116 | FYN | 0.38207655 |
117 | CSF1R | 0.37009667 |
118 | GSK3A | 0.35387233 |
119 | SIK1 | 0.35012990 |
120 | MTOR | 0.33900525 |
121 | SIK2 | 0.33358860 |
122 | ARAF | 0.33221664 |
123 | CAMK1D | 0.32769608 |
124 | MAP3K1 | 0.32516082 |
125 | TSSK6 | 0.32294332 |
126 | FER | 0.32038698 |
127 | PDPK1 | 0.32032870 |
128 | BCR | 0.31232697 |
129 | EPHA2 | 0.31121937 |
130 | MET | 0.30673552 |
131 | MKNK2 | 0.30213906 |
132 | EPHB2 | 0.30123723 |
133 | KSR2 | 0.29623676 |
134 | IGF1R | 0.29095059 |
135 | NEK6 | 0.28413315 |
136 | PDK1 | 0.27044756 |
137 | MAP3K11 | 0.26911704 |
138 | INSR | 0.26706716 |
139 | STK10 | 0.26080617 |
140 | PRKCZ | 0.22952903 |
141 | MOS | 0.22308725 |
142 | RIPK1 | 0.22301823 |
143 | DAPK3 | 0.22168528 |
144 | PIK3CG | 0.18852792 |
145 | SGK1 | 0.18258956 |
146 | PRPF4B | 0.16982160 |
147 | SRC | 0.15155202 |
148 | RPS6KA6 | 0.13908713 |
149 | MELK | 0.13900496 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.34034663 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.37654245 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 3.11783448 |
4 | Legionellosis_Homo sapiens_hsa05134 | 2.99191531 |
5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.98628201 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.78405908 |
7 | Malaria_Homo sapiens_hsa05144 | 2.77562891 |
8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.75901101 |
9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.71266644 |
10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.67613474 |
11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.61904057 |
12 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.59819363 |
13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.56595504 |
14 | Asthma_Homo sapiens_hsa05310 | 2.44567277 |
15 | Pertussis_Homo sapiens_hsa05133 | 2.29369890 |
16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.29271597 |
17 | Bladder cancer_Homo sapiens_hsa05219 | 2.26029332 |
18 | Tuberculosis_Homo sapiens_hsa05152 | 2.22674863 |
19 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.12333175 |
20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.07295950 |
21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06012740 |
22 | Salmonella infection_Homo sapiens_hsa05132 | 1.96330768 |
23 | Measles_Homo sapiens_hsa05162 | 1.82181033 |
24 | Phagosome_Homo sapiens_hsa04145 | 1.69313600 |
25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67017062 |
26 | Influenza A_Homo sapiens_hsa05164 | 1.62335320 |
27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.57722050 |
28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.49010486 |
29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.45688394 |
30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41190602 |
31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.41172228 |
32 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.37474458 |
33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30468786 |
34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.29326963 |
35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26454107 |
36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25213437 |
37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23976563 |
38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.23250622 |
39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20635611 |
40 | Lysosome_Homo sapiens_hsa04142 | 1.18967965 |
41 | Amoebiasis_Homo sapiens_hsa05146 | 1.17791057 |
42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.10896866 |
43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09023589 |
44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08459177 |
45 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.08339245 |
46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07621494 |
47 | Apoptosis_Homo sapiens_hsa04210 | 1.00387323 |
48 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.97789093 |
49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95376733 |
50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89879437 |
51 | Prion diseases_Homo sapiens_hsa05020 | 0.89605621 |
52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.88516693 |
53 | Hepatitis B_Homo sapiens_hsa05161 | 0.83124105 |
54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82466135 |
55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.81578967 |
56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80966791 |
57 | Shigellosis_Homo sapiens_hsa05131 | 0.80918576 |
58 | Hepatitis C_Homo sapiens_hsa05160 | 0.75126030 |
59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74695969 |
60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73500175 |
61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71272310 |
62 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70995259 |
63 | Mineral absorption_Homo sapiens_hsa04978 | 0.69991593 |
64 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.67497896 |
65 | Focal adhesion_Homo sapiens_hsa04510 | 0.66314127 |
66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64946336 |
67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63912871 |
68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63521264 |
69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61052630 |
70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60358076 |
71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60348376 |
72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58028723 |
73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57818776 |
74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54314263 |
75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54007845 |
76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53933186 |
77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.53572936 |
78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52013541 |
79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51204294 |
80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50239649 |
81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48910092 |
82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47902870 |
83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47041901 |
84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46848301 |
85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46307569 |
86 | Prostate cancer_Homo sapiens_hsa05215 | 0.42405774 |
87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41780394 |
88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41503035 |
89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41280530 |
90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41154987 |
91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40139993 |
92 | Endocytosis_Homo sapiens_hsa04144 | 0.40104044 |
93 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39616969 |
94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39345072 |
95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38890954 |
96 | Melanoma_Homo sapiens_hsa05218 | 0.38471115 |
97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37533224 |
98 | Platelet activation_Homo sapiens_hsa04611 | 0.37054654 |
99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.35736091 |
100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35419869 |
101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35022440 |
102 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.32232786 |
103 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.31723136 |
104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.30157806 |
105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29258353 |
106 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.27894019 |
107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27729131 |
108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27322062 |
109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25132814 |
110 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.24962876 |
111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.24562008 |
112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24030280 |
113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.23617350 |
114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20866333 |
115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.18624145 |
116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.17324310 |
117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.17275455 |
118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.17158227 |
119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16431019 |
120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16113544 |
121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.14939153 |
122 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.14055235 |
123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.11381279 |
124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.10098626 |
125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.09748569 |
126 | Adherens junction_Homo sapiens_hsa04520 | 0.08908109 |
127 | Insulin resistance_Homo sapiens_hsa04931 | 0.08689566 |
128 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.08507329 |
129 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.07798374 |
130 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.07311376 |
131 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.07263251 |